Scientists finally have a cellular model of spontaneous tau pathology, thanks to some nifty genetic engineering in the lab of Dominik Paquet, Ludwig Maximilian University, Munich. Scientists there ...
Acquisition Enhances IPSC’s Ability to Expand Operations, Maintenance and Asset Management Capabilities Across the U.S. IHI Power Services Corp. (IPSC), a leading provider of operations and ...
New manufacturing technologies aim to accelerate next-generation cell therapy development Cellistic has unveiled three new GMP manufacturing platforms designed to advance iPSC-derived cell therapies ...
In a report released on November 14, William Maughan from Clear Street maintained a Buy rating on Century Therapeutics, with a price target of $8.00. The company’s shares closed last Friday at $0.47.
Global Induced Pluripotent Stem Cell (iPSC) Market · GlobeNewswire Inc. Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies ...
Human pluripotent stem cells (hPSCs) hold great promise in regenerative medicine. However, immune rejections remain one of the major obstacles to stem cell therapy. Though conventional ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Quebec Premier ...
Researchers across discovery and translational biomedicine recognize the critical importance of iPSCs in core applications beyond regenerative medicine. Large, global biobanks offer researchers ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
iPSC-derived cell models are a widely used tool that enables scientists to generate various cell types, organoids, and tissues. They are also instrumental in creating disease-specific phenotypes using ...
The 5th iPSC Drug Development Summit serves as a pivotal platform for uniting iPSC-based drug developers across the value chain, from research and development through to CMC, to accelerate the ...
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results